PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 35 filers reported holding PSYCHEMEDICS CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,428 | -88.5% | 32,098 | -86.7% | 0.00% | -86.4% |
| Q2 2023 | $1,104,034 | -18.0% | 242,113 | -5.6% | 0.02% | -24.1% |
| Q1 2023 | $1,345,830 | +6.4% | 256,349 | -0.6% | 0.03% | +7.4% |
| Q4 2022 | $1,264,405 | -26.7% | 257,795 | -3.6% | 0.03% | -34.1% |
| Q3 2022 | $1,724,000 | +1.7% | 267,363 | +0.0% | 0.04% | +10.8% |
| Q2 2022 | $1,695,000 | -7.8% | 267,309 | +0.3% | 0.04% | +2.8% |
| Q1 2022 | $1,839,000 | -1.7% | 266,502 | 0.0% | 0.04% | 0.0% |
| Q4 2021 | $1,871,000 | -20.7% | 266,502 | -5.1% | 0.04% | -25.0% |
| Q3 2021 | $2,360,000 | +16.4% | 280,938 | -3.6% | 0.05% | +17.1% |
| Q2 2021 | $2,028,000 | +11.5% | 291,436 | -0.7% | 0.04% | 0.0% |
| Q1 2021 | $1,819,000 | +19.3% | 293,361 | -2.1% | 0.04% | +7.9% |
| Q4 2020 | $1,525,000 | +15.4% | 299,561 | 0.0% | 0.04% | +5.6% |
| Q3 2020 | $1,321,000 | -23.5% | 299,561 | -3.7% | 0.04% | -28.0% |
| Q2 2020 | $1,727,000 | -11.7% | 311,166 | -3.7% | 0.05% | -24.2% |
| Q1 2020 | $1,956,000 | -34.1% | 323,244 | -0.3% | 0.07% | -14.3% |
| Q4 2019 | $2,967,000 | +6.6% | 324,239 | +6.1% | 0.08% | 0.0% |
| Q3 2019 | $2,784,000 | -8.9% | 305,566 | +0.9% | 0.08% | -10.5% |
| Q2 2019 | $3,057,000 | -29.9% | 302,952 | -2.5% | 0.09% | -33.8% |
| Q1 2019 | $4,362,000 | -7.7% | 310,870 | +4.4% | 0.13% | -18.8% |
| Q4 2018 | $4,724,000 | -1.6% | 297,675 | +16.6% | 0.16% | +9.6% |
| Q3 2018 | $4,802,000 | +1.7% | 255,284 | +4.0% | 0.15% | -2.7% |
| Q2 2018 | $4,724,000 | -3.7% | 245,541 | +6.9% | 0.15% | -3.2% |
| Q1 2018 | $4,904,000 | +3.4% | 229,585 | -0.5% | 0.16% | +5.4% |
| Q4 2017 | $4,743,000 | +25.2% | 230,685 | +12.3% | 0.15% | +19.5% |
| Q3 2017 | $3,787,000 | -19.8% | 205,493 | +8.6% | 0.12% | -24.1% |
| Q2 2017 | $4,721,000 | +30.7% | 189,233 | +5.1% | 0.16% | +26.6% |
| Q1 2017 | $3,612,000 | -3.1% | 180,133 | +19.3% | 0.13% | -5.2% |
| Q4 2016 | $3,727,000 | +22.1% | 151,013 | -1.9% | 0.14% | +20.5% |
| Q3 2016 | $3,053,000 | +26.4% | 154,013 | -12.4% | 0.11% | +16.7% |
| Q2 2016 | $2,415,000 | -1.5% | 175,798 | -1.4% | 0.10% | -6.8% |
| Q1 2016 | $2,451,000 | +35.5% | 178,285 | -0.1% | 0.10% | +28.8% |
| Q4 2015 | $1,809,000 | +3.1% | 178,385 | +2.2% | 0.08% | +5.3% |
| Q3 2015 | $1,754,000 | -14.9% | 174,561 | +25.6% | 0.08% | -2.6% |
| Q2 2015 | $2,061,000 | +2.4% | 138,961 | +14.5% | 0.08% | +6.8% |
| Q1 2015 | $2,013,000 | +20.1% | 121,366 | +9.7% | 0.07% | +23.7% |
| Q4 2014 | $1,676,000 | +32.9% | 110,612 | +24.2% | 0.06% | +31.1% |
| Q3 2014 | $1,261,000 | +6.1% | 89,070 | +6.2% | 0.04% | +7.1% |
| Q2 2014 | $1,188,000 | – | 83,870 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
| SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
| Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
| Cannell Capital | 78,306 | $540,000 | 0.08% |
| RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
| CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
| Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
| HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
| Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |